Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

6 September 2011 Medgenics rings the NYSE Closing Bell

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
598 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Sep 6, 2011

On Tuesday, September 6th, executives and guests of Medgenics, Inc. (NYSE Amex: MDGN) visited the New York Stock Exchange (NYSE Amex) to celebrate the company's April 8th, 2011 Listing. President, CEO, and Founder, Dr. Andrew Pearlman Ph.D. rang The Closing Bell.

Interview by NYSE Anthony Drizis

About Medgenics:
Medgenics is developing and commercializing the Bio pump, a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own skin biopsy for the treatment of a range of chronic diseases including anemia, hepatitis C and hemophilia. Medgenics believes this approach has multiple benefits compared with current treatments, which include regular and costly injections of therapeutic proteins.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • Sarah's aunt is the woman closest to the gavel. Mazal Tov on great success for your career, company and the medical world. Kol hakavod.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more